Ad is loading...
JEPAX
Price
$14.87
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
MENRX
Price
$10.15
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

JEPAX vs MENRX

Header iconJEPAX vs MENRX Comparison
Open Charts JEPAX vs MENRXBanner chart's image
JPMorgan Equity Premium Income A
Price$14.87
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Madison Covered Call & Equity Income R6
Price$10.15
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
JEPAX vs MENRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JEPAX vs. MENRX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JEPAX is a StrongBuy and MENRX is a Buy.

FUNDAMENTALS
Fundamentals
JEPAX has more cash in the bank: 6.47B vs. MENRX (245M). MENRX pays higher dividends than JEPAX: MENRX (7.54) vs JEPAX (7.05). JEPAX was incepted earlier than MENRX: JEPAX (6 years) vs MENRX (12 years). JEPAX is a more actively managed with annual turnover of: 189.00 vs. MENRX (102.00). JEPAX has a lower initial minimum investment than MENRX: JEPAX (1000) vs MENRX (500000). JEPAX annual gain was more profitable for investors over the last year : 17.06 vs. MENRX (8.36). MENRX return over 5 years is better than : 61.66 vs. JEPAX (56.61).
JEPAXMENRXJEPAX / MENRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years12 years-
Gain YTD13.8235.382257%
Front LoadN/AN/A-
Min. Initial Investment10005000000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.47B245M2,642%
Annual Yield % from dividends7.057.5494%
Returns for 1 year17.068.36204%
Returns for 3 years24.7720.58120%
Returns for 5 years56.6161.6692%
Returns for 10 yearsN/A69.12-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ODP26.630.77
+2.98%
ODP Corp (The)
FMC58.331.13
+1.98%
FMC Corp
ZVRA9.130.16
+1.78%
Zevra Therapeutics
IKNA1.730.03
+1.76%
Ikena Oncology
AVGO163.940.69
+0.42%
Broadcom Inc.